Cancer research has shown that DCLK1 plays a role in regulating Notch signaling activity (133) which is involved in DM complications such as retinopathy, nephropathy, neuropathy, and cardiomyopathy (96, 103). Here, DCLK1 is linked to cardiomyopathy.